Evidence map›Paper›PMID 39364357›Full record

ArticleEuropean heart journal. Case reports2024

Pannus formation: a rare culprit of early bioprosthetic valve dysfunction-a case report.

Sho Takemoto, Hiroshi Kumano, Junichi Shimamura, Akira Shiose

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sho TakemotoCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, 13th Street, Building 149, Boston, MA 02129, USA.ORCID https://orcid.org/0000-0001-6552-4225
Hiroshi KumanoDepartment of Cardiovascular Surgery, Northern Okinawa Medical Center, 1712-3, Umusa, Nago, Okinawa 905-8611, Japan.
Junichi ShimamuraDivision of Cardiothoracic Surgery, Westchester Medical Center, 100 Woods Rd, Valhalla, NY 10595, USA.ORCID https://orcid.org/0000-0001-7980-5036
Akira ShioseDepartment of Cardiovascular Surgery, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.ORCID https://orcid.org/0000-0002-0865-0169

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early bioprosthetic valve dysfunction (BVD) due to pannus formation is uncommon in elderly patients, and only a limited number of cases have been reported. Case summary: An 84-year-old man presented with exertional dyspnoea 3 years after surgical aortic valve replacement (SAVR) with a 19 mm Epic™ valve (Abbott, Santa Clara, CA, USA). Transthoracic echocardiography demonstrated progressive BVD, and cardiac computed tomography (CT) revealed sub-aortic pannus formation. Re-operative SAVR was performed using a 19 mm INSPIRIS RESILIA® valve (Edwards Lifesciences, Irvine, CA, USA), and pathological examination confirmed valve leaflet deformation caused by pannus overgrowth. At the 18-month follow-up, the patient exhibited favourable progress, with no indications of BVD or pannus recurrence. Discussion: This case highlights the importance of recognizing early pannus formation as a cause of BVD, even in elderly patients. Early detection of BVD based on clinical symptoms and echocardiography is vital to allow timely surgical intervention before the deterioration of cardiac function. Cardiac CT helps to differentiate pannus from thrombus formation and guide treatment decisions.

Indexed as

Bioprosthetic valve dysfunctionCase reportElderly patientPannusSurgical aortic valve replacement

Identifiers

PMID39364357
PMCPMC11448332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.